Role and Function of MicroRNAs in Extracellular Vesicles in Cardiovascular Biology

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Pfeifer, Philipp ^a   Werner, Nikos ^a   Jansen, Felix ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

CARDIOVASCULAR DISEASE; CELL COMMUNICATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EXOSOME; GENE EXPRESSION; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; ANIMAL; BIOLOGICAL MODEL; MEDICAL RESEARCH; MOUSE;

ANIMALS; BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; EXTRACELLULAR VESICLES; HUMANS; MICE; MICRORNAS; MODELS, CARDIOVASCULAR;

EID: 84945323772     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/161393     Document Type: Review

References (81)

1. M. Colombo, G. Raposo, and C. Thery, "Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles, " Annual Review of Cell and Developmental Biology, vol. 30, no. 1, pp. 255-289, 2014.
2. S. F. Mause and C. Weber, "Microparticles: protagonists of a novel communication network for intercellular information exchange, " Circulation Research, vol. 107, no. 9, pp. 1047-1057, 2010.
3. F. Dignat-George and C. M. Boulanger, "The many faces of endothelial microparticles, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 1, pp. 27-33, 2011.
4. H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J. J. Lee, and J. O. Lotvall, "Exosome-mediated transfer of mRNAs and micro RNAs is a novel mechanism of genetic exchange between cells, " Nature Cell Biology, vol. 9, no. 6, pp. 654-659, 2007
5. V. Cantaluppi, S. Gatti, D. Medica et al., "Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent repro-gramming of resident renal cells, " Kidney International, vol. 82, no. 4, pp. 412-427, 2012.
6. P. Diehl, A. Fricke, L. Sander et al., "Microparticles: major transport vehicles for distinct microRNAs in circulation, " Cardiovascular Research, vol. 93, no. 4, pp. 633-644, 2012.
7. X. Loyer, A.-C. Vion, A. Tedgui, and C. M. Boulanger, "Microvesicles as cell-cell messengers in cardiovascular diseases, " Circulation Research, vol. 114, no. 2, pp. 345-353, 2014.
8. E. M. Small, R. J. A. Frost, and E. N. Olson, "MicroRNAs add a new dimension to cardiovascular disease, " Circulation, vol. 121, no. 8, pp. 1022-1032, 2010.
9. J.-J. Song, S. K. Smith, G. J. Hannon, and L. Joshua-Tor, "Crystal structure of Argonaute and its implications for RISC sheer activity, " Science, vol. 305, no. 5689, pp. 1434-1437, 2004.
10. S. Djuranovic, A. Nahvi, and R. Green, "A parsimonious model for gene regulation by miRNAs, " Science, vol. 331, no. 6017, pp. 550-553, 2011.
11. J. D. Arroyo, J. R. Chevillet, E. M. Kroh et al., "Argonaute2 complexes carry a population of circulating micro RNAs independent of vesicles in human plasma, " Proceedings of the 'National Academy of Sciences of the United States of America, vol. 108, no. 12, pp. 5003-5008, 2011.
12. K. G Vickers, B. T. Palmisano, B. M. Shoucri, R. D. Shamburek, and A. T. Remaley, "MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, " Nature Cell Biology, vol. 13, no. 4, pp. 423-433, 2011.
13. R. A. Boon and K. C. Vickers, "Intercellular transport of MicroRNAs, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 2, pp. 186-192, 2013.
14. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., "Circulating microRNAs as stable blood-based markers for cancer detection, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513-10518, 2008.
15. S. Fichtlscherer, S. De Rosa, H. Fox et al., "Circulating microRNAs in patients with coronary artery disease, " Circulation Research, vol. 107, no. 5, pp. 677-684, 2010.
16. A. Schober, M. Nazari-Jahantigh, and G Weber, "microRNA-mediated mechanisms of the cellular stress response in atherosclerosis, " Nature Reviews Cardiology, vol. 12, no. 6, pp. 361-374, 2015.
17. E. Hergenreider, S. Heydt, K. Treguer et al., "Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs, " Nature Cell Biology, vol. 14, no. 3, pp. 249-256, 2012.
18. W. D. Gray, K. M. French, S. Ghosh-Choudhary et al., "Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology, " Circulation Research, vol. 116, no. 2, pp. 255-263, 2015.
19. S.-G Ong, W. H. Lee, M. Huang et al., "Cross talk of combined gene and cell therapy in ischemic heart disease, " Circulation Research, pp. 1-25, 2014.
20. F. Jansen, X. Yang, M. Hoelscher et al., "Endothelial microparticle-mediated transfer of microRNA-126 promotes vascular endothelial cell repair via spredl and is abrogated in glucose-damaged endothelial microparticles, " Circulation, vol. 128, no. 18, pp. 2026-2038, 2013.
21. G. K. Hansson, "Inflammation, atherosclerosis, and coronary artery disease, " The New England journal of Medicine, vol. 352, no. 16, pp. 1685-1695, 2005.
22. J. E. Fish and M. I. Cybulsky, "ApoE attenuates atherosclerosis via miR-146a, " Circulation Research, vol. 117, no. 1, pp. 3-6, 2015.
23. S. Meiler, Y. Baumer, E. Toulmin, K. Seng, and W. A. Boisvert, "MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 2, pp. 323-331, 2015.
24. Y Zhang, W. Qin, L. Zhang et al., "MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis, " Scientific Reports, vol. 5, pp. 9401-9410, 2015.
25. F. Jansen, X. Yang, K. Baumann et al., "Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism, " journal of Cellular and Molecular Medicine, 2015.
26. NTR-dependent activation of NF-/cB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemia, " Nature Communications, vol. 6, article 8024, 13 pages, 2015.
27. K. Di Gregoli, N. Jenkins, R. Salter, S. White, A. C. Newby, and J. L. Johnson, "MicroRNA-24 regulates macrophage behavior and retards atherosclerosis, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 9, pp. 1990-2000, 2014.
28. A. Schober, M. Nazari-Jahantigh, Y Wei et al., "Micro RNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlkl, " Nature Medicine, vol. 20, no. 4, pp. 368-376, 2014.
29. X. Sun, S. He, A. K. M. Wara et al, "Systemic delivery of microRNA-181b inhibits nuclear factor-/cB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice, " Circulation Research, vol. 114, no. 1, pp. 32-40, 2014.
30. A. Zernecke, K. Bidzhekov, H. Noels et al., "Delivery of microRNA-126 by apoptotic bodies induces CXCL12-depend-ent vascular protection, " Science Signaling, vol. 2, no. 100, article ra81, 2009.
31. M. Climent, M. Quintavalle, M. Miragoli, J. Chen, G. Con-dorelli, and L. Elia, "TGF/5 triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization, " Circulation Research, vol. 116, no. 11, pp. 1753-1764, 2015.
32. F. Jansen, X. Yang, S. Proebsting et al., "MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease, " journal of the American Heart Association, vol. 3, no. 6, Article ID e001249, 2014.
33. P.-E. Rautou, A. S. Leroyer, B. Ramkhelawon et al., "Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration, " Circulation Research, vol. 108, no. 3, pp. 335-343, 2011.
34. K.-C. Wang, L. X. Garmire, A. Young et al., "Role of micro RNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 7, pp. 3234-3239, 2010.
35. C. Urbich, D. Kaluza, T. Fromel et al., "MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A, " Blood, vol. 119, no. 6, pp. 1607-1618, 2012.
36. D. J. Son, S. Kumar, W. Takabe et al., "The atypical mechanosen-sitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis, " Nature Communications, vol. 4, article 3000, 15 pages, 2013.
37. A.-C. Vion, B. Ramkhelawon, X Loyer et al., "Shear stress regulates endothelial microparticle release, " Circulation Research, vol. 112, no. 10, pp. 1323-1333, 2013.
38. J. Zhou, K.-C. Wang, W. Wu et al., "MicroRNA-21 targets peroxisome proliferators-activated receptor-a in an autoregula-tory loop to modulate flow-induced endothelial inflammation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 25, pp. 10355-10360, 2011.
39. X. Loyer, S. Potteaux, A.-C. Vion et al., "Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice, " Circulation Research, vol. 114, no. 3, pp. 434-443, 2014.
40. W. Wu, H. Xiao, A. Laguna-Fernandez et al., "Flow-dependent regulation of kriippel-like factor 2 is mediated by MicroRNA-92a, " Circulation, vol. 124, no. 5, pp. 633-641, 2011.
41. Y. Fang and P. E Davies, "Site-specific microRNA-92a regulation of Kriippel-like factors 4 and 2 in atherosusceptible endothelium, " Arteriosclerosis, Thrombosis, and VascularBiology, vo\. 32, no. 4, pp. 979-987, 2012.
42. Y. Fang, C. Shi, E. Manduchi, M. Civelek, and P. E Davies, "MicroRNA-lOa regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 30, pp. 13450-13455, 2010.
43. J. Zhou, K.-C. Wang, W. Wu et al, "microRNA-21 targets peroxisome proliferators-activated receptor-a in an autoregula-tory loop to modulate flow-induced endothelial inflammation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 25, pp. 10355-10360, 2011.
44. X. Qin, X. Wang, Y Wang et al., "MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin Dl expression in human umbilical vein endothelial cells, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 7, pp. 3240-3244, 2010.
45. E Lovren, Y Pan, A. Quan et al., "MicroRNA-145 targeted therapy reduces atherosclerosis, " Circulation, vol. 126, no. 11, pp. S81-S90, 2012.
46. A. Zampetaki, S. Kiechl, I. Drozdov et al., "Plasma MicroRNA profiling reveals loss of endothelial MiR-126 and other MicroR-NAs in type 2 diabetes, " Circulation Research, vol. 107, no. 6, pp. 810-817, 2010.
47. E Fleissner, V. Jazbutyte, J. Fiedler et al., "Asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a Micro RNA-21-dependent mechanism, " Circulation Research, vol. 107, no. 1, pp. 138-143, 2010.
48. J.-M. Daniel, D. Penzkofer, R. Teske et al., "Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury, " Cardiovascular Research, vol. 103, no. 4, pp. 564-572, 2014.
49. L. Poliseno, A. Tuccoli, L. Mariani et al., "MicroRNAs modulate the angiogenic properties of HUVECs, " Blood, vol. 108, no. 9, pp. 3068-3071, 2006.
50. Q. Zhang, I. Kandic, and M. J. Kutryk, "Dysregulation of angiogenesis-related micro RNAs in endothelial progenitor cells from patients with coronary artery disease, " Biochemical and Biophysical Research Communications, vol. 405, no. 1, pp. 42-46, 2011.
51. Z. Xu, Y Han, J. Liu et al, "MiR-135b-5p and MiR-499a-3p promote cell proliferation and migration in atherosclerosis by directly targeting MEF2C, " Scientific Reports, vol. 5, Article ID 12276, 2015.
52. H. S. Cheng, N. Sivachandran, A. Lau et al., "MicroRNA-146 represses endothelial activation by inhibitingpro-inflammatory pathways, " EMBO Molecular Medicine, vol. 5, no. 7, pp. 1017-1034, 2013.
53. E Jansen, X Yang, B. S. Franklin et al., "High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation, " Cardiovascular Research, vol. 98, no. 1, pp. 94-106, 2013.
54. R. C. Lai, E Arslan, M. M. Lee et al., "Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury, " Stem Cell Research, vol. 4, no. 3, pp. 214-222, 2010.
55. C. M. Boulanger, A. Scoazec, T. Ebrahimian et al., "Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction, " Circulation, vol. 104, no. 22, pp. 2649-2652, 2001.
56. E. van Rooij, L. B. Sutherland, N. Liu et al., "A signature pattern of stress-responsive micro RNAs that can evoke cardiac hypertrophy and heart failure, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 48, pp. 18255-18260, 2006.
57. C. Bang, S. Batkai, S. Dangwal et al., "Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate car-diomyocyte hypertrophy, " The Journal of Clinical Investigation, vol. 124, no. 5, pp. 2136-2146, 2014.
58. J. Halkein, S. P. Tabruyn, M. Ricke-Hoch et al, "MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy, " Journal of Clinical Investigation, vol. 123, no. 5, pp. 2143-2154, 2013.
59. L. Barile, V. Lionetti, E. Cervio et al., "Extracellular vesicles fromhuman cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function aftermyocardial infarction, " Cardiovascular Research, vol. 103, no. 4, pp. 530-541, 2014.
60. A. G.-E. Ibrahim, K. Cheng, and E. Marban, "Exosomes as critical agents of cardiac regeneration triggered by cell therapy, " Stem Cell Reports, vol. 2, no. 5, pp. 606-619, 2014.
61. R. Roncarati, C. V. Anselmi, M. A. Losi et al., "Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy, " Journal of the American College of Cardiology, vol. 63, no. 9, pp. 920-927, 2014.
62. N. Nair, S. Kumar, E. Gongora, and S. Gupta, "Circulating miRNA as novel markers for diastolic dysfunction, " Molecular and Cellular Biochemistry, vol. 376, no. 1-2, pp. 33-40, 2013.
63. M. Jaguszewski, J. Osipova, J.-R. Ghadri et al., "A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction, " European Heart Journal, vol. 35, no. 15, pp. 999-1006, 2014.
64. C. Guay, V. Menoud, S. Rome, and R. Regazzi, "Horizontal transfer of exosomal microRNAs transduce apoptotic signals between pancreatic beta-cells, " Cell Communication and Signaling, vol. 13, article 17, 2015.
65. E Barutta, M. Tricarico, A. Corbelli et al., "Urinary exosomal MicroRNAs in incipient diabetic nephropathy, " PLoS ONE, vol. 8, no. 11, Article ID e73798, 2013.
66. + PBMCs: role for proangiogenic effects and alterations in type 2 diabetics, " Blood, vol. 121, no. 1, pp. 226-236, 2013.
67. E. van Rooij and E. N. Olson, "MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles, " Nature Reviews Drug Discovery, vol. 11, no. 11, pp. 860-872, 2012.
68. H. L. A. Janssen, H. W. Reesink, E. J. Lawitz et al., "Treatment of HCV infection by targeting microRNA, " The New England Journal of Medicine, vol. 368, no. 18, pp. 1685-1694, 2013.
69. J. Fiedler, V. Jazbutyte, B. C. Kirchmaier et al, "MicroRNA-24 regulates vascularity after myocardial infarction, " Circulation, vol. 124, no. 6, pp. 720-730, 2011.
70. R. Kumarswamy, I. Volkmann, V. Jazbutyte, S. Dangwal, D.-H. Park, and T. Thum, "Transforming growth factor-jS-induced endothelial-to-mesenchymal transition is partly mediated by MicroRNA-21, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 2, pp. 361-369, 2012.
71. E. van Rooij, L. B. Sutherland, J. E. Thatcher et al., "Dysregula-tion of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 13027-13032, 2008.
72. G. Santulli, A. Wronska, K. Uryu et al., "A selective microRNA-based strategy inhibits restenosis while preserving endothelial function, " The journal of Clinical Investigation, vol. 124, no. 9, pp. 4102-4114, 2014.
73. N. Nouraee and S. J. Mowla, "miRNA therapeutics in cardiovascular diseases: promises and problems, " Frontiers in Genetics, vol. 6, article 232, 2015.
74. Y. Zhang, D. Liu, X. Chen et al., "Secreted monocytic miR-150 enhances targeted endothelial cell migration, " Molecular Cell, vol. 39, no. 1, pp. 133-144, 2010.
75. C. J. Cheng and W. M. Saltzman, "Polymer nanoparticle-mediated delivery of MicroRNA inhibition and alternative splicing, " Molecular Pharmaceutics, vol. 9, no. 5, pp. 1481-1488, 2012.
76. I. A. Babar, C. J. Cheng, C. J. Booth et al., "Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 26, pp. E1695-E1704, 2012.
77. S. Anand, B. K. Majeti, L. M. Acevedo et al., "MicroRNA-132-mediated loss of pl20RasGAP activates the endothelium to facilitate pathological angiogenesis, " Nature Medicine, vol. 16, no. 8, pp. 909-914, 2010.
78. Y. Chen, X. Zhu, X Zhang, B. Liu, and L. Huang, "Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy, " Molecular Therapy, vol. 18, no. 9, pp. 1650-1656, 2010.
79. J. Su, H. Baigude, J. McCarroll, and T. M. Rana, "Silencing microRNA by interfering nanoparticles in mice, " Nucleic Acids Research, vol. 39, no. 6, article e38, 2011.
80. G. Mullokandov, A. Baccarini, A. Ruzo et al., "High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries, " Nature Methods, vol. 9, no. 8, pp. 840-846, 2012.
81. M. Li and J. Zhang, "Circulating microRNAs: potential and emerging biomarkers for diagnosis of cardiovascular and cerebrovascular diseases, " BioMed Research International, vol. 2015, Article ID 730535, 9 pages, 2015.